Kamil Ali-jackson - Net Worth and Insider Trading
Kamil Ali-jackson Net Worth
The estimated net worth of Kamil Ali-jackson is at least $210,810 dollars as of 2024-04-27. Kamil Ali-jackson is the Chief Legal Officer of Aclaris Therapeutics Inc and owns about 143,618 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $172,342. Kamil Ali-jackson is also the Director of PDS Biotechnology Corp and owns about 11,764 shares of PDS Biotechnology Corp (PDSB) stock worth over $38,468. Details can be seen in Kamil Ali-jackson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kamil Ali-jackson has not made any transactions after 2021-06-15 and currently still holds the listed stock(s).
Transaction Summary of Kamil Ali-jackson
Kamil Ali-jackson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kamil Ali-jackson owns 3 companies in total, including PDS Biotechnology Corp (PDSB) , Aclaris Therapeutics Inc (ACRS) , and Rigel Pharmaceuticals Inc (RIGL) .
Click here to see the complete history of Kamil Ali-jackson’s form 4 insider trades.
Insider Ownership Summary of Kamil Ali-jackson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PDSB | PDS Biotechnology Corp | 2021-06-15 | director |
| ACRS | Aclaris Therapeutics Inc | 2021-05-07 | Chief Legal Officer |
| RIGL | Rigel Pharmaceuticals Inc | 2022-05-20 | director |
Kamil Ali-jackson Latest Holdings Summary
Kamil Ali-jackson currently owns a total of 2 stocks. Among these stocks, Kamil Ali-jackson owns 143,618 shares of Aclaris Therapeutics Inc (ACRS) as of May 7, 2021, with a value of $172,342 and a weighting of 81.75%. Kamil Ali-jackson also owns 11,764 shares of PDS Biotechnology Corp (PDSB) as of June 15, 2021, with a value of $38,468 and a weighting of 18.25%.
Latest Holdings of Kamil Ali-jackson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc | 2021-05-07 | 143,618 | 1.20 | 172,342 |
| PDSB | PDS Biotechnology Corp | 2021-06-15 | 11,764 | 3.27 | 38,468 |
Holding Weightings of Kamil Ali-jackson
Kamil Ali-jackson Form 4 Trading Tracker
According to the SEC Form 4 filings, Kamil Ali-jackson has made a total of 2 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Aclaris Therapeutics Inc is the sale of 20,416 shares on May 7, 2021, which brought Kamil Ali-jackson around $478,755.
According to the SEC Form 4 filings, Kamil Ali-jackson has made a total of 1 transactions in PDS Biotechnology Corp (PDSB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in PDS Biotechnology Corp is the acquisition of 11,764 shares on June 15, 2021, which cost Kamil Ali-jackson around $99,994.
Insider Trading History of Kamil Ali-jackson
- 1
Kamil Ali-jackson Trading Performance
GuruFocus tracks the stock performance after each of Kamil Ali-jackson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kamil Ali-jackson is 66.3%. GuruFocus also compares Kamil Ali-jackson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kamil Ali-jackson within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kamil Ali-jackson's insider trading performs compared to the benchmark.
Performance of Kamil Ali-jackson
Average Return
-64.89%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.2 | 66.3 | -2.5 | -64.89 | -17.78 | |
| Relative Return to S&P 500(%) | 3.53 | 60.79 | -13.41 | -54.14 | -19.87 |
Kamil Ali-jackson Ownership Network
Ownership Network List of Kamil Ali-jackson
Ownership Network Relation of Kamil Ali-jackson
Kamil Ali-jackson Owned Company Details
What does PDS Biotechnology Corp do?
Who are the key executives at PDS Biotechnology Corp?
Kamil Ali-jackson is the director of PDS Biotechnology Corp. Other key executives at PDS Biotechnology Corp include Senior VP & General Counsel Spencer D. Brown , Chief Financial Officer Matthew C Hill , and director & 10 percent owner Delyle W Bloomquist .
PDS Biotechnology Corp (PDSB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of PDS Biotechnology Corp (PDSB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDS Biotechnology Corp (PDSB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
PDS Biotechnology Corp (PDSB)'s detailed insider trading history can be found in Insider Trading Tracker table.
PDS Biotechnology Corp Insider Transactions
Kamil Ali-jackson Mailing Address
Above is the net worth, insider trading, and ownership report for Kamil Ali-jackson. You might contact Kamil Ali-jackson via mailing address: C/o Aclaris Therapeutics, Inc., 101 Lindenwood Drive, Suite 400, Malvern Pa 19355.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
